Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcos Malumbres

Cancer cell

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer Cell|June 14, 2011
Oncogene-induced mitotic stress: p53 and pRb get mad tooMarcos Malumbres
Cancer Cell|October 20, 2012
Cell cycle-based therapies move forwardMarcos Malumbres
Cancer Cell|March 16, 2016
CDK4/6 Inhibitors resTORe Therapeutic Sensitivity in HER²⁺ Breast CancerMarcos Malumbres
Cancer Cell|January 18, 2006
Is Cyclin D1-CDK4 kinase a bona fide cancer target?Marcos Malumbres, Mariano Barbacid
Cancer Cell|April 15, 2020
Mechanisms of Sensitivity and Resistance to CDK4/6 InhibitionMónica Álvarez-Fernández, Marcos Malumbres
Cancer Cell|June 14, 2005
Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1)Alberto Martín, Junko Odajima, Sarah L Hunt, et al.
Cancer Cell|December 16, 2010
Targeting mitotic exit leads to tumor regression in vivo: Modulation by Cdk1, Mastl, and the PP2A/B55α,δ phosphataseEusebio Manchado, María Guillamot, Guillermo de Cárcer, et al.
Cancer Cell|June 10, 2008
Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expressionMaría J Bueno, Ignacio Pérez de Castro, Marta Gómez de Cedrón, et al.
Cancer Cell|February 29, 2020
CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic AdenocarcinomaBeatriz Salvador-Barbero, Mónica Álvarez-Fernández, Elisabet Zapatero-Solana, et al.
Cancer Cell|August 17, 2013
A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesisKaroline Kollmann, Gerwin Heller, Christine Schneckenleithner, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer Cell|June 14, 2011
Oncogene-induced mitotic stress: p53 and pRb get mad tooMarcos Malumbres
Cancer Cell|October 20, 2012
Cell cycle-based therapies move forwardMarcos Malumbres
Cancer Cell|March 16, 2016
CDK4/6 Inhibitors resTORe Therapeutic Sensitivity in HER²⁺ Breast CancerMarcos Malumbres
Cancer Cell|January 18, 2006
Is Cyclin D1-CDK4 kinase a bona fide cancer target?Marcos Malumbres, Mariano Barbacid
Cancer Cell|April 15, 2020
Mechanisms of Sensitivity and Resistance to CDK4/6 InhibitionMónica Álvarez-Fernández, Marcos Malumbres
Cancer Cell|June 14, 2005
Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1)Alberto Martín, Junko Odajima, Sarah L Hunt, et al.
Cancer Cell|December 16, 2010
Targeting mitotic exit leads to tumor regression in vivo: Modulation by Cdk1, Mastl, and the PP2A/B55α,δ phosphataseEusebio Manchado, María Guillamot, Guillermo de Cárcer, et al.
Cancer Cell|June 10, 2008
Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expressionMaría J Bueno, Ignacio Pérez de Castro, Marta Gómez de Cedrón, et al.
Cancer Cell|February 29, 2020
CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic AdenocarcinomaBeatriz Salvador-Barbero, Mónica Álvarez-Fernández, Elisabet Zapatero-Solana, et al.
Cancer Cell|August 17, 2013
A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesisKaroline Kollmann, Gerwin Heller, Christine Schneckenleithner, et al.
Pageof 1